Letters to the editor for Feb. 26.
William Blair reiterated their market perform rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a report issued on Tuesday,RTT News reports. Other research analysts have also ...
At Tuesday's event, PayPal rolled out its fiscal 2027 targets, including for 8% to 10% growth in branded checkout volume. That's up from the 6% growth seen in the latest quarter. On the whole as a ...
William Blair analyst Adam Klauber maintained a Buy rating on Baldwin Insurance Group (BWIN – Research Report) today. The company’s shares ...
In a report released today, Brian Drab from William Blair maintained a Buy rating on Novanta (NOVT – Research Report). The company’s shares ...
Stock analysts at William Blair lowered their Q1 2025 EPS estimates for shares of AMN Healthcare Services in a report issued ...
Blair Murphy delved into the words of William Shakespeare not from the perspective of just a reader or even a scholar, but as ...
WJCC leaders will consider a potential name change for the school building on Longhill Road and, if approved, the ...
This article is published as part of The Telegraph’s Greatest Interviews series, which revisits the most significant, ...
KYIV, Ukraine-The U.S. and Ukraine pushed divergent messages over the weekend, with Kyiv pressing for better terms to the mineral-rights deal sought by President Trump, while Washington urged Ukraine ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
Blair Murphy delved into the words of William Shakespeare not from the perspective of just a reader or even a scholar, but as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results